Larimar Therapeutics, Inc. (LRMR) Ownership

$3.96

south_east
-$0.22 (-5.26%)
Day's range
$3.96
Day's range
$4.25

Larimar Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 02/14/2025 21.23 M $82.17 M   0.00% 33.28%
JANUS HENDERSON GROUP PLC 02/14/2025 6.44 M $24.94 M   15.74% 10.10%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 6.05 M $23.40 M   0.00% 9.47%
BLUE OWL CAPITAL HOLDINGS LP 02/14/2025 4.65 M $18.01 M   11.67% 7.29%
GOLDMAN SACHS GROUP INC 02/11/2025 4.15 M $16.07 M   -2.29% 6.51%
BLACKROCK FUNDING, INC. /DE 02/07/2025 3.27 M $12.64 M   9.85% 5.12%
VANGUARD GROUP INC 02/11/2025 2.19 M $8.49 M   -4.54% 3.44%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 2.10 M $8.13 M   23.47% 3.29%
DRIEHAUS CAPITAL MANAGEMENT LLC 02/14/2025 1.27 M $4.91 M   -0.72% 1.99%
VERITION FUND MANAGEMENT LLC 02/14/2025 1.04 M $4.02 M   -10.67% 1.63%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 984,077 $3.81 M   38.57% 1.54%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 886,414 $3.43 M   -1.65% 1.39%
MANGROVE PARTNERS 02/14/2025 770,233 $2.98 M   -10.00% 1.21%
FRED ALGER MANAGEMENT, LLC 02/14/2025 737,553 $2.85 M   -6.23% 1.16%
WOODLINE PARTNERS LP 02/14/2025 622,682 $2.41 M   -49.97% 0.98%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 513,542 $1.99 M   45.13% 0.80%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 505,000 $1.95 M   -27.13% 0.79%
SPHERA FUNDS MANAGEMENT LTD. 02/14/2025 455,604 $1.76 M   9.92% 0.71%
ALTIUM CAPITAL MANAGEMENT LP 02/13/2025 396,000 $1.53 M   102.04% 0.62%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 371,434 $1.44 M   -24.85% 0.58%
MILLENNIUM MANAGEMENT LLC 02/14/2025 254,947 $986,645   -66.62% 0.40%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 233,873 $905,087   278.79% 0.37%
ASSENAGON ASSET MANAGEMENT S.A. 01/14/2025 219,987 $851,350   -2.86% 0.34%
UBS OCONNOR LLC 02/14/2025 188,543 $729,661   -7.02% 0.30%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 174,788 $676,430   0.00% 0.27%
GSA CAPITAL PARTNERS LLP 02/07/2025 148,533 $575,000   38.29% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 125,127 $484,241   0.00% 0.20%
TREXQUANT INVESTMENT LP 02/12/2025 123,066 $476,265   -18.56% 0.19%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 116,067 $449,179   10.28% 0.18%
MARSHALL WACE, LLP 02/13/2025 110,304 $426,876   52.16% 0.17%
JUMP FINANCIAL, LLC 02/13/2025 107,544 $416,195   13.62% 0.17%
BANK OF NEW YORK MELLON CORP 02/04/2025 100,453 $388,754   1.85% 0.16%
TWO SIGMA INVESTMENTS, LP 02/14/2025 85,788 $332,000   -28.22% 0.13%
DIMENSIONAL FUND ADVISORS LP 02/13/2025 81,150 $314,051   -24.09% 0.13%
BALYASNY ASSET MANAGEMENT L.P. 02/14/2025 79,496 $307,650   100.00% 0.12%
BARCLAYS PLC 02/13/2025 70,425 $273,000   17.31% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 67,579 $261,531   224.01% 0.11%
TWO SIGMA ADVISERS, LP 02/14/2025 67,024 $259,383   -30.99% 0.11%
XTX TOPCO LTD 02/13/2025 63,810 $246,945   316.27% 0.10%
IKARIAN CAPITAL, LLC 02/14/2025 58,526 $226,496   0.00% 0.09%
STATE OF WISCONSIN INVESTMENT BOARD 02/14/2025 57,958 $224,297   46.41% 0.09%
AMERICAN CENTURY COMPANIES INC 02/11/2025 56,294 $217,858   32.76% 0.09%
RHUMBLINE ADVISERS 01/30/2025 56,200 $217,486   0.93% 0.09%
ENTRYPOINT CAPITAL, LLC 02/11/2025 54,281 $210,067   197.66% 0.09%
UBS GROUP AG 02/14/2025 53,131 $205,617   167.34% 0.08%
ALPS ADVISORS INC 02/13/2025 51,590 $199,653   100.00% 0.08%
02/10/2025 47,100 $182,277   100.00% 0.07%
FMR LLC 02/13/2025 44,203 $171,066   -91.61% 0.07%
DEUTSCHE BANK AG\ 02/14/2025 44,052 $170,481   -84.38% 0.07%
CITIGROUP INC 02/12/2025 35,675 $138,062   17.52% 0.06%

Larimar Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 140 institutional investors and hedge funds held shares of Larimar Therapeutics, Inc.. The most heavily invested institutionals were:

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 21.23 M

JANUS HENDERSON GROUP PLC: 6.44 M

RA CAPITAL MANAGEMENT, L.P.: 6.05 M

Blue Owl Capital Holdings LP: 4.65 M

GOLDMAN SACHS GROUP INC: 4.15 M

BlackRock Funding, Inc. /DE: 3.27 M

99.41% of Larimar Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 69.25 M shares in the last 24 months. This purchase volume represents approximately $274.21 M in transactions.